Cantor Fitzgerald Starts ORIC Pharamceuticals (ORIC) at Overweight, 'offers attractive risk/reward'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: ORIC) | Delayed: 9.34 -0.25 (2.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.59 | 52 Week High | $ | |||
| Open | $9.98 | 52 Week Low | $ | |||
| Day High | $10.13 | P/E | N/A | |||
| Day Low | $9.07 | EPS | $ | |||
| Volume | 2,958,659 | |||||
